Product How it works Pricing Blog FAQ About Contact
Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ: IRWD) net income

Ironwood Pharmaceuticals reported a net profit of $24.0m for fiscal 2025, 2,629.2% more than in fiscal 2024 ($0.9m). Its net margin was 8.1%. Earnings per share were $0.15.

Ironwood Pharmaceuticals's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2022, −66.9%. It reported a loss in 4 of those 10 years.

Net income, in millions of US dollars-81.72016-116.92017-282.4201821.52019106.22020528.42021175.12022-1,00220230.9202424.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$24.0m+2,629.2%8.1%$0.15
2024$0.9m—0.3%$0.01
2023−$1,002m−672.5%−226.4%−$6.45
2022$175.1m−66.9%42.6%$1.13
2021$528.4m+397.7%127.7%$3.26
2020$106.2m+393.7%27.3%$0.67
2019$21.5m—5.0%$0.14
2018−$282.4m—−81.5%−$1.85
2017−$116.9m—−39.2%—
2016−$81.7m—−29.8%—

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Ironwood Pharmaceuticals net income compared with its sector

By net income for its latest fiscal year, Ironwood Pharmaceuticals ranks 142nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Ironwood Pharmaceuticals, 8.1%.

RankCompanyNet incomeNet margin
140thGoodRx$30.4m3.8%
141stPennant Group$29.6m3.1%
142ndIronwood Pharmaceuticals$24.0m8.1%
143rdSiga Technologies$23.3m24.6%
144thPrivia Health Group$22.9m1.1%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of Ironwood Pharmaceuticals

How much did Ironwood Pharmaceuticals earn in fiscal 2025?
Ironwood Pharmaceuticals reported a net profit of $24.0m for fiscal 2025. In fiscal 2024 it reported a net profit of $0.9m.
What are the earnings per share of Ironwood Pharmaceuticals?
They were $0.15 in fiscal 2025, compared with $0.01 in fiscal 2024.
What is the net margin of Ironwood Pharmaceuticals?
In fiscal 2025 its net profit was 8.1% of its revenue.
What was the most profitable year for Ironwood Pharmaceuticals?
Of its last 10 fiscal years, fiscal 2021, with $528.4m.
Where does Ironwood Pharmaceuticals rank in its sector by net income?
It ranks 142nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for Ironwood Pharmaceuticals come from?
From the annual report (Form 10-K) that Ironwood Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Ironwood Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Ironwood Pharmaceuticals: the Ironwood Pharmaceuticals page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.